R. Axelrod

发表

Fractionated stereotactic radiotherapy with cis-platinum radiosensitization in the treatment of recurrent, progressive, or persistent malignant astrocytoma.

D. Andrews, B. Corn, C. Silverman, 1997, American journal of clinical oncology.

B. Leiby, Yunfeng Cui, M. Witek, 2014, American journal of clinical oncology.

A randomized phase II study of ixabepilone (BMS-247550) given daily x 5 days every 3 weeks or weekly in patients with metastatic or recurrent squamous cell cancer of the head and neck: an Eastern Cooperative Oncology Group study.

J. Manola, A. Argiris, B. Burtness, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase i study of 'dose-dense' pemetrexed plus carboplatin/radiotherapy for locally advanced non-small cell lung carcinoma

W. Curran, M. Werner-wasik, P. Gilman, 2011, Radiation oncology.

Phase I trial using patupilone (epothilone B) and concurrent radiotherapy for central nervous system malignancies.

W. Curran, A. Dicker, D. Andrews, 2010, International journal of radiation oncology, biology, physics.

In reply [6]

B. Movsas, Colum J Smith, C. Langer, 2005 .

Tadalafil Enhances Immune Signatures in Response to Neoadjuvant Nivolumab in Resectable Head and Neck Squamous Cell Carcinoma

J. Netterville, B. Leiby, A. Argiris, 2021, Clinical cancer research : an official journal of the American Association for Cancer Research.

A phase II trial of PS-341 (bortezomib) followed by the addition of doxorubicin at progression in incurable adenoid cystic carcinoma of the head and neck: An Eastern Cooperative Oncology Group study.

C. Van Waes, A. Argiris, M. Goldwasser, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pilot study of carboplatin/radiotherapy plus 'dose-dense' pemetrexed for locally advanced non-small cell lung carcinoma

W. Curran, M. Machtay, P. Gilman, 2008 .

PARTNER: An open-label, randomized, phase 2 study of docetaxel/cisplatin chemotherapy with or without panitumumab as first-line treatment for recurrent or metastatic squamous cell carcinoma of the head and neck.

S. Dakhil, P. Debruyne, L. Wirth, 2016, Oral oncology.

Pathologic Correlation of PET-CT Based Auto Contouring for Radiation Planning in Lung Cancer

Maria Werner-Wasik, Shannon Fogh, Charles M. Intenzo, 2010 .

A phase 1b trial of the combination of the antiangiogenic agent sunitinib and radiation therapy for patients with primary and metastatic central nervous system malignancies

W. Curran, K. Camphausen, T. Hyslop, 2011, Cancer.

Phase I Trial Using Induction Ciplatin, Docetaxel, 5-FU and Erlotinib Followed by Cisplatin, Bevacizumab and Erlotinib With Concurrent Radiotherapy for Advanced Head and Neck Cancer

A. Dicker, P. Anné, R. Axelrod, 2016, American journal of clinical oncology.

Final Report of a Pilot Study of Carboplatin Plus Dose Dense Pemetrexed and Radiotherapy for Locally-advanced Non–small-cell Lung Carcinoma

W. Curran, P. Gilman, R. Axelrod, 2009 .

A phase II trial of preoperative paclitaxel, carboplatin, 5-FU and radiation in patients with resectable esophageal or gastric cancer (Ca)

W. Curran, E. Mitchell, P. Anné, 2004 .

A pilot study of hypofractionated stereotactic radiation therapy and sunitinib in previously irradiated patients with recurrent high-grade glioma.

James J. Evans, W. Curran, K. Camphausen, 2014, International journal of radiation oncology, biology, physics.

A randomized phase II study of BMS-247550 (ixabepilone) given daily x 5 days every 3 weeks or weekly in patients with metastatic or recurrent squamous cell cancer of the head and neck.

A. Argiris, M. Goldwasser, B. Burtness, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase I trial of the combination of the antiangiogenic agent sunitinib and radiation therapy for patients with primary and metastatic central nervous system malignancies

W. Curran, A. Dicker, A. Lin, 2008 .

Value of Fluoro-2-Deoxy-D-Glucose-Positron Emission Tomography for Detecting Metastatic Lesions in Head and Neck Cancer

G. Kubicek, S. Fogh, R. Axelrod, 2012, American journal of clinical oncology.

672P Nivolumab (Nivo) and ipilimumab (Ipi) combined with radiotherapy (RT) in patients (pts) with locally advanced squamous cell carcinoma of the head and neck (LA SCCHN): Updated results on efficacy and correlative analysis

A. Argiris, R. Axelrod, D. Cognetti, 2022, Annals of Oncology.

Neutrophil to lymphocyte ratio associated with prognosis of lung cancer

M. Werner-wasik, V. Bar-ad, R. Myers, 2017, Clinical and Translational Oncology.

A phase II trial of VNP40101M in patients with relapsed or refractory small cell lung cancer (SCLC) with or without brain metastases

S. Gettinger, T. Mekhail, D. Spigel, 2007 .

Randomized trial of amifostine in locally advanced non-small cell lung cancer (NSCLC) patients receiving chemotherapy and hyperfractionated radiation (HRT): Long-term survival results of Radiation Therapy Oncology Group (RTOG) 9801

Benjamin Movsas, Nicos Nicolaou, R. Komaki, 2007 .

PARTNER: A randomized phase II study of docetaxel/cisplatin (doc/cis) chemotherapy with or without panitumumab (pmab) as first-line treatment (tx) for recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN).

S. Dakhil, P. Debruyne, L. Wirth, 2013 .

Nivolumab and ipilimumab in combination with radiotherapy in patients with high-risk locally advanced squamous cell carcinoma of the head and neck

A. Argiris, M. Mahoney, J. Curry, 2023, Journal for ImmunoTherapy of Cancer.

In-field toxicity analysis of a phase I clinical trial of nivolumab and ipilimumab with definitive radiation therapy in locally advanced squamous cell carcinoma of the head and neck: In-Field toxicity of immune-RT in LA-SCCHN.

A. Argiris, V. Bar-ad, R. Axelrod, 2023, International journal of radiation oncology, biology, physics.

A phase 1b trial of the combination of the antiangiogenic agent sunitinib and radiation therapy for patients with primary and metastatic central nervous system malignancies

W. Curran, K. Camphausen, T. Hyslop, 2011, Cancer.